{"id":426169,"title":"Register of Innovative Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-01","captureTimestamp":"2026-01-01T11:48:37.336000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/register-innovative-drugs.html","snippet":"N/A 2019-04-05 2025-04-05 N/A 2027-04-05 abrocitinib 245854 Cibinqo Pfizer Canada ULC N/A 2022-06-29 2028-06-29 Yes 2030-12-29 acalabrutinib 214504 Calquence AstraZeneca Canada Inc.","rawSnapshotUrl":"/api/snapshots/raw/426169","browseUrl":"https://replay.healtharchive.ca/job-6/20260101114837/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/register-innovative-drugs.html#ha_snapshot=426169","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}